These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26810644)

  • 21. Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells.
    Shimoyama K; Kagawa S; Ishida M; Watanabe S; Noma K; Takehara K; Tazawa H; Hashimoto Y; Tanabe S; Matsuoka J; Kobayashi H; Fujiwara T
    Breast Cancer Res Treat; 2015 Feb; 149(3):597-605. PubMed ID: 25616354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near infrared photoimmunotherapy for lung metastases.
    Sato K; Nagaya T; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Lett; 2015 Aug; 365(1):112-21. PubMed ID: 26021765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model.
    Sato K; Nagaya T; Nakamura Y; Harada T; Choyke PL; Kobayashi H
    Oncotarget; 2015 Aug; 6(23):19747-58. PubMed ID: 25992770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.
    Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H
    Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate.
    Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X
    Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin.
    Nishinaga Y; Sato K; Yasui H; Taki S; Takahashi K; Shimizu M; Endo R; Koike C; Kuramoto N; Nakamura S; Fukui T; Yukawa H; Baba Y; K Kaneko M; Chen-Yoshikawa TF; Kobayashi H; Kato Y; Hasegawa Y
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer.
    Yamaguchi H; Pantarat N; Suzuki T; Evdokiou A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green.
    Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
    Cancer Sci; 2021 Mar; 112(3):1326-1330. PubMed ID: 33543819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Mol Cancer Res; 2017 Sep; 15(9):1153-1162. PubMed ID: 28588059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
    Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
    Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy.
    Nakajima K; Miyazaki F; Terada K; Takakura H; Suzuki M; Ogawa M
    Int J Pharm; 2021 Nov; 609():121135. PubMed ID: 34571072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
    Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model.
    Yamashita-Kashima Y; Shu S; Harada N; Fujimoto-Ouchi K
    Oncol Rep; 2013 Sep; 30(3):1087-93. PubMed ID: 23783223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.
    Kishimoto S; Oshima N; Yamamoto K; Munasinghe J; Ardenkjaer-Larsen JH; Mitchell JB; Choyke PL; Krishna MC
    Free Radic Biol Med; 2018 Feb; 116():1-10. PubMed ID: 29289705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
    Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
    Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
    Hamano S; Mori Y; Aoyama M; Kataoka H; Tanaka M; Ebi M; Kubota E; Mizoshita T; Tanida S; Johnston RN; Asai K; Joh T
    Cancer Lett; 2015 Jan; 356(2 Pt B):846-54. PubMed ID: 25444894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.